ACTSI Newsletter
|
Trouble viewing this email? Click here
to view on the web.
| |
| |  | 
ACTSI Weekly eRoundup
September 11, 2015
|
| |
| | | | The ACTSI Tracking & Evaluation program is conducting a Needs Assessment Survey to gather information regarding the ACTSI resources you may have used, or resources and support that you would like to be offered. The survey data will remain anonymous and will be reported in aggregate. This survey should take you no more than 10 minutes to complete. For more information, please contact Dr. Meltem Alemdar, director, ACTSI Tracking & Evaluation, at meltem.alemdar@ceismc.gatech.edu. Thank you in advance for helping the ACTSI to better serve the Atlanta research community. | | | | Begin Survey | | |
| |
| | | | | ACTSI-supported researcher, Han Phan, MD, (Children's Healthcare of Atlanta) is collaborating with the inVentive Health Clinical to evaluate the safety and efficacy of a genetic treatment (exon skipping) of Duchenne Muscular Dystrophy. The study is first-of-its-kind in Georgia and is being conducted in ACTSI's Pediatric Clinical Research Unit at Children's Healthcare of Atlanta at Egleston. One of her study participants "Blue" was featured recently ... | | | | Read More | | |
|
| |
| | | | Emory and its partners are applying to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to receive support for a Center for Diabetes Translation Research. The mission of the center is to facilitate and grow diabetes translation research at Emory, its partner institutions, regionally, and nationally. This Request for Pilot and Feasibility Applications is a solicitation for one-page proposals that focus on type II translational research in diabetes care and prevention. Faculty researchers from Emory, Morehouse School of Medicine, the Atlanta VA, Georgia Tech, and Georgia State University are eligible. | | | | Read More | | |
| |
| | | | This seed grant competition is an opportunity for the scientific and business community including entrepreneurs, clinicians, scientists, businesses, academic researchers, and medical and engineering graduate and undergraduate students, to develop and commercialize a pediatric medical device. | | | | Read More | | |
| |
| | | | This grants program is designed to meet these aims through the provision of funding and technical assistance to community-based organizations (CBOs) to strengthen an existing community academic partnership by supporting their dissemination activities. The CERP invites proposals from CBOs in an established partnership with academic researchers affiliated with Morehouse School of Medicine, Emory University, or Georgia Tech. Selected partnerships must have already completed a community-engaged research project and must use the funds for dissemination activities. | | | | Read More | | |
| |
| | | | This grants program is designed to meet these aims through the provision of funding and technical assistance to community-based organizations (CBOs) to build capacity and skills to conduct research in collaboration with academic researchers. The CERP invites proposals from CBOs interested in conducting a research project in partnership with academic researchers affiliated with Morehouse School of Medicine, Emory University, or Georgia Tech. CBOs can request that CERP help them find an academic partner or CBOs can request a grant for a pilot study to be conducted with an existing academic partner from one of the three ACTSI universities. | | | | Read More | | |
| |
| | | | The proposed research direction must reflect ideas substantially different from those already being pursued in the investigator¿s research program or elsewhere; not intended to expand a current research program's funding. The award will support individuals with a trajectory of success, who propose novel approaches to major research challenges in CV and/or stroke that have the potential to produce unusually high impact. | | | | Read More | | |
| |
| | | | The Barth Syndrome Foundation, Inc. (BSF) announce the availability of funding for basic science and clinical research on the natural history, biochemical basis, and treatment of Barth syndrome (cardinal characteristics: cardiomyopathy, neutropenia, underdeveloped skeletal musculature and muscle weakness, growth delay, exercise intolerance, cardiolipin abnormalities, 3-methylglutaconic aciduria). | | | | Read More | | |
| |
| | | | This grant welcomes your most innovative ideas and encourages you to submit abstracts within evolving research areas that include: Multicolor flow cytometry, cell signaling, stem cell research, immune function, infectious diseases, and neuroscience research. | | | | Read More | | |
| |
| | | | The purpose of this FOA is to provide an immunologic reagent resource that will support and advance the optimal use of non-human primate (NHP) models of vaccine and adjuvant development and infectious and immune-mediated diseases, including transplantation. | | | | Read More | | |
| |
| | | | This FOA will support the conduct of advanced clinical trials designed to test the outpatient clinical safety and efficacy of artificial pancreas (AP) device systems in type 1 diabetes with the objective of improving glycemic control, reducing acute complications, and improving quality of life. | | | | Read More | | |
| |
| | | | Active clinical, translational, or basic research investigators are invited to participate in the Discovery Phase of the Emory Medical School curriculum by serving as mentors for a medical student research project. | | | | Read More | | |
| |
| | | | The over-arching goal of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation¿s biomedical, behavioral and clinical research needs. | | | | Read More | | |
| |
| | | | Students, postdoctoral fellows, and early and mid-career scientists are eligible for fellowships to conduct research and participate in activities that encourage professional growth in a new area. Funds may be available for stipends, housing, travel, and ASM membership. | | | | Read More | | |
| |
| | | | If you have a research ethics question or are pondering a research ethics dilemma, John Banja, Professor of Rehabilitation Medicine, Emory, and Rebecca Pentz, Professor of Research Ethics in Hematology and Oncology, Winship, are available to confidentially discuss it and offer non-binding advice. Please call or email John at 404-712-4804/jbanja@emory.edu or call or text Becky at 404-831-1758. | | | | Read More | | |
| |
| | | | | Breakfast with Division Director, NIH Center for Scientific Review-Monday
All welcome to attend an informal opportunity to meet Karyl Swartz, PhD, Division Director, Center for Scientific Review, National Institutes for Health in Emory’s Health Sciences Research Building, Café at 8:00 a.m. Please RSVP if you plan to attend.
K-Club
Open to ALL! Presented by Karyl Swartz, PhD, Division Director, Center for Scientific Review, National Institutes ... | | | | Learn More | | |
|
| |
| | | | Hosted by Grady¿s Offices of Research and Grants Administration, this session will address how to obtain approval for clinical trials and research at Grady and provide a step-by-step overview of managing your trial and research at Grady. | | | | Read More | | |
| |
| | | ACTSI’s Community Engagement Research Program presents a free Grant Writing Skill-building Workshop to help develop successful community-driven grant applications. Space is limited. ... | | | | Read More | | |
| |
| | | | Presented by Martin Blakely, MD, Monroe Carell Jr. Children's Hospital at Vanderbilt and sponsored by Clinical Outcomes Research and Public Health. | | | | Read More | | |
| |
| | | | The conference, held at Morehouse School of Medicine, is designed to heighten participants' awareness on a variety of topics relative to Personalized Medicine. Featuring keynote speaker Eliseo Perez-Stable, NIMHD director. | | | | Read More | | |
| |
| | | | MSM¿s R-Center Study Design, Biostatistics, & Data Management Core presents Gelcys Campo, PharmD, Merck & Company, Inc. Medical Affairs Director, U.S. Medical Affairs Health Systems | | | | Read More | | |
| |
| | | | Keynote speaker: Gary H. Gibbons, MD, Director of the National Heart, Lung, and Blood Institute (NHLBI) | | | | Read More | | |
| |
| | | | Learn how to build surveys and project databases, export files, and collect and enter data in REDCap. Hands-on assistance and demonstrations available | | | | Read More | | |
| |
| | | | The Institute for Electronics and Nanotechnology (IEN) offers this new short course that is designed for individuals interested in hands-on training in the fabrication of microfluidic devices using the soft lithography. Open to academia, industry, and government. | | | | Read More | | |
| |
| | | | The program is geared toward new investigators and extramural research administrators who wish to learn more about the NIH grants application and award processes. | | | | Read More | | |
| |
| | | | | Sponsored by ACTSI, the event will include didactic lectures about the microbiome, presentations by various Emory Core facilities, a demonstration of an oral microbiome collection, and much more. Microbiome enthusiasm at Emory ... | | | | Read More | | |
|
| |
| | | Debra Houry, MD, ACTSI investigator, director of the CDC National Center for Injury Prevention and Control, and associate professor at Emory University School of Medicine
CDC | WHSC | Debra Houry, MD, named director of the CDC National Center for Injury Prevention and Control
September 18, 2014
Houry received the 2014 Dean's Teaching Award. Recipients of the award are nominated by colleagues and students and chosen by the Emory’s Teaching ... | | | | Read More | | |
| |
| For more information on ACTSI, please visit
www.actsi.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
actsi@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
actsi@emory.edu.
Please include the following citation in any publications resulting from direct or indirect ACTSI support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2 TR000455 and TL1 Trainees should also list TL1 TR000456. |
| |
|
